{"DataElement":{"publicId":"2548424","version":"1","preferredName":"Invasive Breast Carcinoma Change Type","preferredDefinition":"Text term to identify any other benign findings within the breast specimen.","longName":"INV_BRSTCA_CHG_TP","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2548420","version":"1","preferredName":"Invasive Breast Carcinoma Other Change","preferredDefinition":"Other changes in an invasive breast carcinoma specimen.","longName":"INV_BRSTCA_OTX_CHG","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2508844","version":"1","preferredName":"Invasive Breast Carcinoma","preferredDefinition":"marked by a tendency to spread especially into healthy tissue.:A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter's syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002","longName":"C14159:C4872","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B277965-06BA-0143-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-16","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-08-16","modifiedBy":"ONEDATA","dateModified":"2006-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2549634","version":"1","preferredName":"Other Change","preferredDefinition":"Not otherwise specified.:alteration or modification.","longName":"C17649:C25446","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23D34897-37B7-470D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-04","modifiedBy":"ONEDATA","dateModified":"2006-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23C0416C-6569-3B1D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2548422","version":"1","preferredName":"Invasive Breast Carcinoma Change Type","preferredDefinition":"Text terms to identify changes to an invasive breast carcinoma specimen.","longName":"INV_BRSTCA_CHG_TP","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Papilloma","valueDescription":"Papilloma","ValueMeaning":{"publicId":"2575025","version":"1","preferredName":"Papilloma","longName":"2575025","preferredDefinition":"Papilloma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F21E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-23","modifiedBy":"REEVESD","dateModified":"2005-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23C05275-051C-3CEE-E044-0003BA3F9857","beginDate":"2006-12-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-03","modifiedBy":"REEVESD","dateModified":"2006-12-03","deletedIndicator":"No"},{"value":"Sclerosing adenosis","valueDescription":"SCLEROSING ADENOSIS","ValueMeaning":{"publicId":"2566483","version":"1","preferredName":"SCLEROSING ADENOSIS","longName":"2566483","preferredDefinition":"SCLEROSING ADENOSIS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0C0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23C05275-0528-3CEE-E044-0003BA3F9857","beginDate":"2006-12-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-03","modifiedBy":"REEVESD","dateModified":"2006-12-03","deletedIndicator":"No"},{"value":"Radial scar","valueDescription":"RADIAL SCAR","ValueMeaning":{"publicId":"2566481","version":"1","preferredName":"RADIAL SCAR","longName":"2566481","preferredDefinition":"RADIAL SCAR","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radial Scar/Complex Sclerosing Lesion","conceptCode":"C9495","definition":"A benign breast lesion characterized by the presence of fibrosis with stellate appearance in the parenchyma.  The lesions are often multiple and bilateral.  Grossly, the lesions are irregular and firm and resemble carcinoma.  Microscopically, the stellate lesions are composed of dense, hyalinized collagen.  Entrapped in the collagen are tubules.  There is no evidence of cytologic atypia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0BE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23C05275-0534-3CEE-E044-0003BA3F9857","beginDate":"2006-12-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-03","modifiedBy":"REEVESD","dateModified":"2006-12-03","deletedIndicator":"No"},{"value":"Fibroadenoma","valueDescription":"Fibroadenoma","ValueMeaning":{"publicId":"2566468","version":"1","preferredName":"Fibroadenoma","longName":"2566468","preferredDefinition":"This is the most common benign breast lesion.  It usually occurs in premenopausal women.  Diagnostic exams and procedures include: clinical exam, imaging (mammography and ultra sound), and tissue biopsy (fine-needle aspiration or core biopsy). -2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Fibroadenoma","conceptCode":"C3744","definition":"A benign tumor of the breast characterized by the presence of stromal and epithelial elements. It presents as a painless, solitary, slow growing, firm, and mobile mass. It is the most common benign breast lesion. It usually occurs in women of childbearing age. The majority of fibroadenomas do not recur after complete excision. A slightly increased risk of developing cancer within fibroadenomas or in the breast tissue of patients previously treated for fibroadenomas has been reported.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0B1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-11","modifiedBy":"REEVESD","dateModified":"2010-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23C05275-0540-3CEE-E044-0003BA3F9857","beginDate":"2006-12-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-03","modifiedBy":"REEVESD","dateModified":"2006-12-03","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23C05275-054C-3CEE-E044-0003BA3F9857","beginDate":"2006-12-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-03","modifiedBy":"REEVESD","dateModified":"2006-12-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2548421","version":"1","preferredName":"Invasive Breast Carcinoma Change Type","preferredDefinition":"Marked by a tendency to spread especially into healthy tissue.:A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter's syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002:alteration or modification.:Type; a subdivision of a particular kind of thing.","longName":"C14159:C4872:C25446:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23C0416C-6580-3B1D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-03","modifiedBy":"ONEDATA","dateModified":"2006-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23C0416C-6591-3B1D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-03","modifiedBy":"REEVESD","dateModified":"2010-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2548333","version":"1","longName":"I-SPY","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812254","version":"1","longName":"C911/C1000","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Other changes present?","type":"Preferred Question Text","description":"Other changes present?","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"23C06D31-44BF-3F35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-03","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":"Curated to create I-SPY data collection forms.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}